 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Glucose-Dependent Insulinotropic Peptide Level Is Associated with the Development of Type 2 Diabetes Mellitus |
| Sunghwan Suh, Mi Yeon Kim, Soo Kyoung Kim, Kyu Yeon Hur, Mi Kyoung Park, Duk Kyu Kim, Nam H. Cho, Moon-Kyu Lee |
|
Endocrinol Metab. 2016;31(1):134-141. Published online March 16, 2016 DOI: https://doi.org/10.3803/EnM.2016.31.1.134 |
|
Glucose-dependent insulinotropic peptide level is associated with the development of type 2 diabetes mellitus Diabetes Research and Clinical Practice. 2016;120:S68  The Incretins and Pancreatic β-Cells: Use of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide to Cure Type 2 Diabetes Mellitus Korean Diabetes Journal. 2010;34(1):2 Serum Glucose-Dependent Insulinotropic Polypeptide in Gestational Diabetes Mellitus Metabolism. 2021;116:154644 Pharmacodynamics, pharmacokinetics and safety of multiple ascending doses of the novel dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 agonist RG7697 in people with type 2 diabetes mellitus Diabetes, Obesity and Metabolism. 2017;19(10):1436-1445 Glucose-Dependent Insulinotropic Peptide Level Is Associated with the Development of Type 2 Diabetes Mellitus Endocrinology and Metabolism. 2016;31(1):134 The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with Type 2 (non-insulin-dependent) diabetes mellitus Diabetologia. 1989;32(9): Efficacy and safety of high‐dose glucagon‐like peptide‐1, glucagon‐like peptide‐1/glucose‐dependent insulinotropic peptide, and glucagon‐like peptide‐1/glucagon receptor agonists in type 2 diabetes Diabetes, Obesity and Metabolism. 2022;24(5):788-805 A supplementary infusion of glucose-dependent insulinotropic polypeptide (GIP) with a meal does not significantly improve the β cell response or glucose tolerance in type 2 diabetes mellitus Diabetes Research and Clinical Practice. 1989;7(4):263-269 Single-dose acarbose decreased glucose-dependent insulinotropic peptide and glucagon levels in Chinese patients with newly diagnosed type 2 diabetes mellitus after a mixed meal BMC Endocrine Disorders. 2016;16(1): Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas Journal of Diabetes Investigation. 2013;4(2):108-130 |
